Optimal Antiplatelet Therapy In NSTE-ACS: Results From A Novel Crowdsourcing Survey
July 07 ,2021
Overview:The choice and duration of antiplatelet therapy in NSTE-ACS undergoing PCI is complex and is a hotly debated topic – particularly amongst patients at high bleeding risk. To gain insight into the real-world practices of a global cross-section of cardiologists, Radcliffe Medical Education, in partnership with the International Society of Cardiovascular Pharmacotherapy (ISCP), undertook a novel […] more
Dapagliflozin safely reduces kidney failure risk, cardiovascular mortality in advanced CKD
July 27 ,2021
Overview:An analysis of DAPA-CKD data showed dapagliflozin reduces the risk for kidney failure and mortality in patients with advanced chronic kidney disease, a subgroup that made up 14% of the study population included in the initial trial.Further, researchers deemed the drug safe after observing no increased risk for serious adverse events when compared with patients who had less severe stages of chronic kidney disease.“This analysis shows that the effects of dapagliflozin in patients with stage 4 CKD are similar to effects in patients with mild to moderate CKD,” Glenn M. Chertow, MD, more
Cleveland Clinic named best US hospital for cardiology, heart surgery
July 27 ,2021
Overview:Cleveland Clinic has been selected by U.S. News & World Report as the top U.S. hospital for cardiology and heart surgery, in the publication’s 2021-2022 Best Hospitals rankings.“It’s a great honor to, again, be No. 1 for 27 years. It’s very humbling and it’s a great source of pride for our team because we go all out to serve our patients in the best way possible,” Lars Svensson, MD, PhD, chairman of Cleveland Clinic’s Heart, Vascular & Thoracic Institute, told Healio. “We do a lot of research and look at new ways to take care of patients more
Patient autonomy to place do-not-resuscitate order low in COVID-19 hospitalization
July 27 ,2021
Overview:Among high-risk patients, discussion of do-not-resuscitate orders should take place prior to hospitalization, as only 10% of patients possessed the autonomy to do so after admission for severe COVID-19, a speaker reported.“CPR, as it was initially conceived, was reserved for patients in cardiac arrest who are in a good state of health prior to the event. It has since evolved into the standard of care for cardiac arrest in all patients,” Johnathan Kirupakaran, DO, a chief resident in the department of medicine at Woodhull Medical Center in Brooklyn, New York, said during a more
Mayo Clinic retains its status as best US hospital
July 27 ,2021
Overview:Mayo Clinic was ranked the No. 1 hospital nationwide and received the top spot in U.S. News & World Report’s Honor Roll for the 6th straight year, according to a U.S. News press release.“We are truly grateful to our extraordinary staff for always putting our patients’ needs first in the exceptional care that they provide,” Gianrico Farrugia, MD, the president and CEO of Mayo Clinic, said in a Mayo press release.The top 20 institutions that U.S. News recognized for “delivering exceptional treatment across multiple areas of care” for 2021-2022 were:In more
Secondary mitral regurgitation in HF yields worse outcomes, yet valve repair rare
July 27 ,2021
Overview:Despite secondary mitral regurgitation in patients with HF being common and associated with mortality, surgical or transcatheter valve repair was seldom performed in this population, researchers reported.Philipp E. Bartko, MD, PhD, of the department of internal medicine at Medical University of Vienna, and colleagues conducted an observational cohort study to determine the prevalence, long-term outcomes and treatment standards of secondary mitral regurgitation across the HF spectrum. They used data from the Viennese community health care provider network from 2010 to 2020, which included more
Chance for early HF diagnosis in a primary care setting missed for many women, Black patients
July 27 ,2021
Overview:Women and Black individuals are more likely to be diagnosed with HF in an acute care setting than a primary care setting compared men and white patients, respectively, according to data published in Circulation: Heart Failure.Researchers also reported that low net worth and occupation status (“homemaker” or “retired”) were also associated with elevated odds of receiving a first HF diagnosis in an acute setting compared with a primary care setting.“Patients diagnosed with heart failure in the emergency room or during inpatient hospitalization often have more more
Educating residents about cardiac rehabilitation may improve referral rates
July 26 ,2021
Overview:Referrals for cardiac rehabilitation for eligible patients increased after internal medicine residents were exposed to an educational lecture and handout, a speaker reported.Although the number of referrals increased, further investigations with larger studies are needed because this study was not powered to detect significance, according to a presentation at the American Society for Preventive Cardiology Congress on CVD Prevention.“Despite long-standing well-established evidence showing that cardiac rehabilitation reduces cardiovascular mortality by 26% and hospitalization rates by more
MINOCA not benign, should be treated as a syndrome
July 26 ,2021
Overview:Patients with MI or ischemia without obstructive CAD are at elevated risk for poor CV outcomes and doctors need to pinpoint the cause of ischemia, according to a speaker.“MINOCA is a syndrome, not a diagnosis,” Martha Gulati, MD, MS, FACC, FAHA, FASPC, editor-in-chief of CardioSmart from the American College of Cardiology and president-elect of the American Society for Preventive Cardiology, said during a presentation at the virtual ASPC Congress on CVD Prevention.Many doctors were taught in medical school that obstructive CAD is what leads to CV events, but “obstructive CAD more
Angiotensin receptor blockers may be preferable to ACE inhibitors due to safety profile
July 26 ,2021
Overview:Angiotensin receptor blockers don’t significantly differ compared with ACE inhibitors as first-line treatment for patients with hypertension, but do present with a better safety profile, researchers reported.“In professional guidelines, several classes of medications are equally recommended as first-line therapies,” RuiJun Chen, MD, MA, postdoctoral research scientist in the department of biomedical informatics at Columbia University Irving Medical Center and assistant professor in the department of translational data science and informatics at Geisinger, Danville, more
Lancet Women and CVD Commission: Reducing the global burden by 2030
July 26 ,2021
Overview:Despite advances in the prevention and treatment of CVD, it remains the leading cause of death in women and men worldwide. Additionally, the absolute burden of CVD mortality in the U.S. is higher in women than in men.The underlying reasons for the observed health disparity between men and women are complex and reflect disparities in risk factor awareness, prevention and optimal medical treatment.There has been an increasing focus on developing a sex-based approach to asking complex scientific questions that have led to an improved understanding of the underlying differences in the more
Algorithm developed for managing suspected ACS in patients hospitalized with COVID-19
July 25 ,2021
Overview:Diagnosis of ACS in concomitant COVID-19 infection can be made difficult due to an overlap of symptoms, fewer patients presenting to the hospital and a lack of guidance diagnosing hospitalized patients, a speaker reported.At the virtual American Society for Preventive Cardiology Congress on CVD Prevention, Amit Khera, MD, MSc, FACC, FAHA, FASPC, immediate past president of the ASPC and professor of medicine, director of preventive cardiology and the Dallas Heart Ball chair in hypertension and heart disease at UT Southwestern Medical Center, discussed the etiologies of ACS and COVID-19 more
‘ABCs’ of primary and secondary CVD prevention have expanded over the years
July 24 ,2021
Overview:The “ABCs” have provided a roadmap for primary and secondary CVD prevention since 1999, according to a speaker at the virtual American Society for Preventive Cardiology Congress on CVD Prevention.Since then, the ABC’s have expanded and were adapted based on changing guidelines and newer evidence-based approaches to care. Cardiology Today Prevention Section Editor Roger S. Blumenthal, MD, FACC, FAHA, Kenneth Jay Pollin Professor of Cardiology and director of the Ciccarone Center for the Prevention of Cardiovascular Disease at Johns Hopkins School of Medicine, discussed these more
BP control key component of CVD prevention
July 23 ,2021
Overview:BP control is an important part of CVD prevention, but better evidence is needed, as is more tailored outreach to at-risk populations, a speaker said at the American Society for Preventive Cardiology Congress on CVD Prevention.Suzanne Oparil, MD, FACC, FAHA, FASH, FAPS, distinguished professor of medicine, professor of cell, developmental and integrated biology, holder of the United Therapeutics Endowed Professorship in Pulmonary Vascular Disease and director of the Vascular Biology and Hypertension Program at the University of Alabama at Birmingham, said in the Leaders in Medicine Lecture more
Women’s heart health strongly related to pregnancy outcomes
July 23 ,2021
Overview:A strong and graded relationship was found between specific CV risk factors presenting in women before pregnancy and pregnancy outcomes, researchers reported in the European Journal of Preventive Cardiology.“Individual cardiovascular risk factors, such as obesity and hypertension, present before pregnancy have been associated with poor outcomes for both mother and baby,” Sadiya S. Khan, MD, MSc, assistant professor of preventive medicine (epidemiology) and medicine (cardiology) at Northwestern University Feinberg School of Medicine, said in a press release. “Our study now more
Ambulatory BP readings may provide best stroke prediction in older adults
July 23 ,2021
Overview:Among older adults, all measures of ambulatory BP were associated with risk for stroke while office diastolic BP was only weakly associated, and central BP measures were not associated with stroke at all, researchers reported.“Based on our results, the widespread use of ambulatory BP monitoring in older adults may be recommended to replace office BP for improving risk stratification for future stroke,” the researchers wrote in a study published in Hypertension.The CABL study investigated CV predictors of subclinical cerebrovascular disease in a community-based cohort of more
Key vascular function parameters may predict eGFR decline in African American patients
July 23 ,2021
Overview:A study of 2,244 African American patients demonstrated certain markers of vascular function, including greater arterial stiffness and pulsatility, were associated with worsening kidney function as measured by eGFR and albuminuria.The findings led Harsha S. Nagarajarao, MD, FACC, of Texas Tech University of Health Sciences in the department of medicine in El Paso, Texas, and colleagues to suggest that vascular function assessments may help predict the risk for the development and progression of kidney disease in this patient population.“Findings in the current investigation show a more
Researchers find ‘racially unequal care’ in most outpatient practices
July 22 ,2021
Overview:Racial and ethnic minority groups were “markedly underrepresented” in outpatient practices across most medical specialties, and those disparities persisted even after researchers accounted for social determinants of access to care.“Two previous studies found that Black and Hispanic Americans had low rates of visits to neurologists, and that minority youth received much less psychiatric care than white youth,” Stephanie Joan Woolhandler, MD, MPH, a lecturer in the department of medicine at the Cambridge Health Alliance, told Healio Primary Care. “However, this is more
Cardiovascular risk in PsA greater for new users of IL-12/23, IL-17 vs. TNF inhibitors
July 22 ,2021
Overview:Despite a low number of major adverse cardiovascular events overall, patients with psoriatic arthritis who newly start IL-12/23 or IL-17 inhibitors have a greater cardiovascular risk than those who begin TNF inhibitors, according to data.“Biological disease-modifying antirheumatic drugs such as TNF, IL12/23 and IL17 inhibitors or targeted synthetic DMARDs (tsDMARDs) are recommended second-line therapies for moderate to severe PsA when standard treatments (including conventional synthetic DMARDs [csDMARDs]) fail to control disease or are not tolerated,” Laura Pina Vegas, a PhD more
In omega-3 fatty acid trials, EPA alone yields greater CV risk reduction vs. EPA plus DHA
July 22 ,2021
Overview:In a meta-analysis of omega-3 fatty acid trials, eicosapentaenoic acid monotherapy yielded the greatest reduction in CV risk vs. a combination of eicosapentaenoic acid and docosahexaenoic acid.“In this systematic review and meta-analysis, we noted moderate certainty of evidence favoring omega-3 fatty acids for reducing CV mortality and outcomes,” Cardiology Today Intervention Section Editor Deepak L. Bhatt, MD, MPH, executive director of interventional cardiovascular programs at the Brigham and Women’s Hospital and professor of medicine at Harvard Medical School, and more
Results of an international crowdsourcing survey on the utilisation of antiplatelet therapy in NSTE-ACS
June 09 ,2021
Overview:Choosing an antiplatelet strategy in patients with non-ST segment elevation acute coronary syndrome (NSTE-ACS) at high bleeding risk (HBR), undergoing percutaneous coronary intervention (PCI), is complex given that one must balance the risk of thrombosis with bleeding events. Since the most recent European guidelines were published in 2020, a number of important original research articles […] more
Hello world!
February 04 ,2021
Overview:Welcome to WordPress. This is your first post. Edit or delete it, then start writing! The post Hello world! appeared first on World Heart Federation. more
ACC.20/WCC Virtual continues!
April 05 ,2020
Overview:The World Heart Federation and American College of Cardiology held their first ever virtual congress March 28-30. But it’s not over. All of the ACC.20/WCC Virtual live sessions are now available on demand, along with additional videos, abstracts and slides — all for FREE. This includes Late-Breaking Clinical Trials, Featured Clinical Research, Young Investigator Awards, Keynotes, and more. All content will […] more
2020 ISCP Annual Meeting cancelled
February 26 ,2020
Overview:Notice of Cancellation We regret to have to inform our colleagues and friends that the 2020 ISCP Annual Scientific Meeting in Miami will now be cancelled. The Board of Directors of ISCP was forced to take the decision based on advice from different sources raising concern about the threat posed by the Covid-19 virus which […] more
European Cardiology Review (ECR) now on PubMed and PubMed Central
October 30 ,2018
Overview: European Cardiology Review (ECR) confirms that it has been accepted for indexing on PubMed Central and PubMed. All ECR articles starting from the first issue in July 2014, will now be published online in full on PubMed Central, providing greater access for our authors’ articles amongst the global cardiology community. ECR is a […] more
WHF to attend the WHO Executive Board meeting in January 2017
January 23 ,2017
Overview:From 23 January to 01 February 2017, the World Health Organization(WHO) will host the 140th session. From 23 January to 01 February 2017, the World Health Organization(WHO) will host the 140th session. From 23 January to 01 February 2017, the World Health Organization(WHO) will host the 140th session. From 23 January to 01 February 2017, […] more